Ikena Oncology logo

Ikena Oncology Share Price Today

(NASDAQ: IKNA)

Ikena Oncology share price is $1.35 & ₹117.41 as on 6 Mar 2025, 2.30 'hrs' IST

$1.35

Market is closed - opens 8 PM, 06 Mar 2025

View live Ikena Oncology share price in Dollar and Rupees. Guide to invest in Ikena Oncology stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Ikena Oncology, along with analyst recommendations, forecasts, and comprehensive financials.

Ikena Oncology share price movements

  • Today's Low: $1.29
    Today's High: $1.37

    Day's Volatility :5.49%

  • 52 Weeks Low: $1.22
    52 Weeks High: $1.94

    52 Weeks Volatility :37.11%

Ikena Oncology (IKNA) Returns

PeriodIkena Oncology IncSector (Health Care)Index (Russel 2000)
3 Months
-19.64%
2.1%
0.0%
6 Months
-18.67%
-4.1%
0.0%
1 Year
-14.56%
2.2%
0.0%
3 Years
-79.33%
11.8%
-11.6%

Ikena Oncology (IKNA) Key Statistics

in dollars & INR

Previous Close
$1.35
Open
$1.3501
Today's High
$1.365
Today's Low
$1.29
Market Capitalization
$62.3M
Today's Volume
$32.4K
52 Week High
$1.94
52 Week Low
$1.22
Revenue TTM
$659.0K
EBITDA
$-63.6M
Earnings Per Share (EPS)
$-1.23
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-37.09%

How to invest in Ikena Oncology Stock (IKNA) from India?

It is very easy for Indian residents to invest directly in Ikena Oncology from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Ikena Oncology stock in both Indian Rupees (INR) and US Dollars (USD). Search for Ikena Oncology or IKNA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Ikena Oncology or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Ikena Oncology shares which would translate to 0.644 fractional shares of Ikena Oncology as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Ikena Oncology, in just a few clicks!

Returns in Ikena Oncology (IKNA) for Indian investors in Rupees

The Ikena Oncology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Ikena Oncology investment value today

Current value as on today

₹90,406

Returns

₹9,594

(-9.59%)

Returns from Ikena Oncology Stock

₹14,557 (-14.56%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Ikena Oncology (IKNA)

-14%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Ikena Oncology Stock from India on INDmoney has decreased by -14% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Ikena Oncology

  • Blue Owl Capital Holdings LP

    8.48%

  • Bvf Inc

    8.30%

  • BML Capital Management LLC

    7.43%

  • Orbimed Advisors, LLC

    7.33%

  • Omega Fund Management LLC

    4.66%

  • Vanguard Group Inc

    2.87%

Analyst Recommendation on Ikena Oncology

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Ikena Oncology(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Ikena Oncology Stock (IKNA)

What analysts predicted

Upside of 122.22%

Target:

$3.00

Current:

$1.35

Insights on Ikena Oncology Stock (Ticker Symbol: IKNA)

  • Price Movement

    In the last 3 years, IKNA stock has moved down by -78.3%
  • Decreasing Revenue

    Revenue is down for the last 6 quarters, 6.40M → 659.0K (in $), with an average decrease of 33.0% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 4 quarters, -19.48M → -10.23M (in $), with an average increase of 24.2% per quarter
  • IKNA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 70.5%
  • IKNA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 126.0%
  • Price to Sales

    ForIKNA every $1 of sales, investors are willing to pay $96.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Ikena Oncology Technicals Summary

Sell

Neutral

Buy

Ikena Oncology is currently in a neutral trading position according to technical analysis indicators.

Ikena Oncology (IKNA) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Ikena Oncology Inc logo
-5.59%
-18.67%
-14.56%
-79.33%
-95.78%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Ikena Oncology Inc logo
5.29
NA
NA
-0.92
-0.37
-0.22
NA
2.78
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Ikena Oncology Inc logo
Buy
$62.3M
-95.78%
5.29
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Ikena Oncology

Ikena Oncology, Inc. operates as an oncology company that develops differentiated therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the United States. Its lead program is IK-930, an internally discovered, oral, TEAD1-selective, small molecule inhibitor of the Hippo pathway. The company also develops IK-595, a molecular glue designed to trap MEK and RAF in an inactive complex. Ikena Oncology, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Organization
Ikena Oncology
Employees
14
CEO
Dr. Mark Manfredi Ph.D.
Industry
Services

Management People of Ikena Oncology

NameTitle
Dr. Mark Manfredi Ph.D.
President, CEO & Director
Dr. Jotin Marango M.D., Ph.D.
CFO & Head of Corporate Development
Ms. Rebecca Cohen
Vice President of Investor Relations, Corporate Strategy & Communication
Mr. Jeffrey Ecsedy Ph.D.
Chief Development Officer
Mr. Bob Lally
Senior Vice President of Finance & Operations
Mr. David Damphousse M.S.
Senior Vice President of Clinical Development Operations
Dr. Caroline Germa M.D., Ph.D.
Chief Medical Officer
Mr. Valdas Jurkauskas Ph.D.
Senior Vice President of Technical Operations

Important FAQs about investing in IKNA Stock from India :

What is Ikena Oncology share price today?

Ikena Oncology share price today stands at $1.35, Open: $1.35 ; Previous Close: $1.35 ; High: $1.37 ; Low: $1.29 ; 52 Week High: $1.94 ; 52 Week Low: $1.22.

The stock opens at $1.35, after a previous close of $1.35. The stock reached a daily high of $1.37 and a low of $1.29, with a 52-week high of $1.94 and a 52-week low of $1.22.

Can Indians buy Ikena Oncology shares?

Yes, Indians can invest in the Ikena Oncology (IKNA) from India.

With INDmoney, you can buy Ikena Oncology at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Ikena Oncology at zero transaction cost.

How can I buy Ikena Oncology shares from India?

It is very easy to buy Ikena Oncology from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Ikena Oncology (IKNA) be purchased?

Yes, you can buy fractional shares of Ikena Oncology with INDmoney app.

What are the documents required to start investing in Ikena Oncology stocks?

To start investing in Ikena Oncology, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Ikena Oncology Stock (IKNA)?

Today’s highest price of Ikena Oncology (IKNA) is $1.37.

Today’s lowest price of Ikena Oncology (IKNA) is $1.29.

What is today's market capitalisation of Ikena Oncology?

Today's market capitalisation of Ikena Oncology IKNA is 62.3M

What is the 52 Week High and Low Range of Ikena Oncology Stock (IKNA)?

  • 52 Week High

    $1.94

  • 52 Week Low

    $1.22

What are the historical returns of Ikena Oncology (IKNA)?

  • 1 Month Returns

    -5.59%

  • 3 Months Returns

    -18.67%

  • 1 Year Returns

    -14.56%

  • 5 Years Returns

    -95.78%

Who is the Chief Executive Officer (CEO) of Ikena Oncology ?

Dr. Mark Manfredi Ph.D. is the current Chief Executive Officer (CEO) of Ikena Oncology.